Moreover, Pathak et al. showed that intestinal FXR activation is responsible for microbiota composition modifications, which will in return activate TGR5 signaling, improving glucose and lipid metabolism in an obesity mouse model, thus suggesting a role in NAFLD and NASH pathogenesis (75). This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.